Pune, India

Pravin Prabhakar Ahirrao



 

Average Co-Inventor Count = 8.9

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Pravin Prabhakar Ahirrao

Introduction

Pravin Prabhakar Ahirrao is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for key medicinal compounds. With a total of 2 patents to his name, Ahirrao's work has had a meaningful impact on drug formulation and production.

Latest Patents

Ahirrao's latest patents include a process for the preparation of fingolimod hydrochloride. This process involves the reaction of 2-(4-octylphenyl)ethyl iodide with diethyl acetamido malonate in the presence of a base and an iodinating agent, resulting in a key intermediate that meets regulatory impurity limits. Another significant patent is for the preparation of zolmitriptan, which outlines a method for isolating (S)-4-(4-hydrazinobenzyl)-1,3-oxazolidin-2-one hydrochloride with desired purity. This method effectively separates undesired inorganic side products by manipulating pH at different stages, ultimately leading to a product that conforms to regulatory specifications.

Career Highlights

Ahirrao is currently associated with Emcure Pharmaceuticals Limited, a prominent player in the pharmaceutical industry. His work at Emcure has allowed him to focus on innovative processes that enhance the quality and efficiency of drug production.

Collaborations

Throughout his career, Ahirrao has collaborated with talented individuals such as Mukund Keshav Gurjar and Prasad Pandurang Panchabhai. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Pravin Prabhakar Ahirrao's contributions to the pharmaceutical industry through his innovative patents and collaborative efforts highlight his commitment to advancing medical science. His work continues to influence the field and improve drug formulation processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…